TRPC6 and urinary tract obstruction: Based on studies in knockout mice, there is evidence that TRPC6 inhibition may be useful to reduce tubulointerstitial fibrosis, especially if it is caused by urinary tract obstruction [64,65,66], and, importantly, these conclusions are supported by pharmacological data [64,89,90].